LBX(SH:603883) Zheng Quan Zhi Xing·2025-04-03 08:13Meeting Overview - The meeting took place in March 2025, with both onsite and online participation [1] - Attendees included representatives from various securities firms and investment funds [1] Cost Reduction and Efficiency Improvement - The company established a special task force for cost reduction and efficiency improvement, focusing on organizational reform and process reengineering [1] - Specific measures include enhancing management efficiency through talent development, standardizing procurement processes, optimizing property resources, and strengthening financial controls [1] Chronic Disease Management Services - The company offers comprehensive health management services for chronic disease patients, utilizing digital tools to enhance service quality and customer retention [2] - As of Q3 2024, the company has established health records for over 16.84 million chronic disease patients, with a higher repurchase rate for chronic disease self-test members compared to regular members [2] - The company has equipped 9,352 stores with free self-testing devices for chronic diseases [2] Franchise Business Strategy - The franchise business is a key strategic focus for the company, leveraging its asset-light model to rapidly expand market presence [3] - The franchise model allows better penetration into county and town markets, benefiting from local franchisees' customer loyalty and resource advantages [3] - The company has a strong brand influence and operational management capabilities, with over 20 years in the pharmaceutical retail industry [3]